• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对真菌和人类拓扑异构酶II的结构见解及其对计算机辅助抗真菌药物设计的启示。

Structural insights into fungal and human topoisomerase II with implications for in silico antifungal drug design.

作者信息

Sappati Subrahmanyam, Kondaka Kavya, Gabriel Iwona, Baginski Maciej

机构信息

Department of Pharmaceutical Technology and Biochemistry, Gdansk University of Technology, Narutowicza St 11/12, 80-233, Gdansk, Poland.

出版信息

Sci Rep. 2025 Mar 19;15(1):9467. doi: 10.1038/s41598-025-93122-1.

DOI:10.1038/s41598-025-93122-1
PMID:40108235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11923201/
Abstract

Topoisomerases are essential enzymes regulating DNA supercoiling and disentanglement, critical for genomic integrity. While topoisomerase inhibitors are well-established in anticancer and antibacterial chemotherapy, their potential as antifungal agents remains underexplored or even not proofed. This study investigates structural distinctions between Saccharomyces cerevisiae topoisomerase II (ScTopoII) and human topoisomerase IIα (hTopoIIα), aiming to identify if ScTopoII can be a selective target for antifungal drug development. A comprehensive sequence analysis, extending to various fungal strains and evolutionary ancient organisms, reveals dissimilarities in the transducer and transducer linker domains of these proteins, as well as in the lysine-rich K-loop region. Molecular dynamics simulations emphasize structural differences in the K-loop, α-helix (or helix-like region), and helix supporting loop region, as well as show unique patterns in hydrophilic and hydrophobic intramolecular interactions in ScTopoII. Moreover, phylogenetic comparisons support the importance of specific regions studied. The study includes topos from different organisms, highlighting discrepancies in helix stability near the K-loop and the role of helix supporting loop region. This broad analysis provides insights into the structural basis of human and fungal enzymes presenting potential pharmacophore "hot spots" in ScTopoII which may give hope for developing selective antifungal agents.

摘要

拓扑异构酶是调节DNA超螺旋和解缠结的必需酶,对基因组完整性至关重要。虽然拓扑异构酶抑制剂在抗癌和抗菌化疗中已得到充分确立,但其作为抗真菌剂的潜力仍未得到充分探索甚至尚未得到证实。本研究调查了酿酒酵母拓扑异构酶II(ScTopoII)和人类拓扑异构酶IIα(hTopoIIα)之间的结构差异,旨在确定ScTopoII是否可以成为抗真菌药物开发的选择性靶点。一项涵盖各种真菌菌株和进化古老生物的全面序列分析揭示了这些蛋白质的转导结构域和转导连接结构域以及富含赖氨酸的K环区域存在差异。分子动力学模拟强调了K环、α螺旋(或螺旋样区域)和螺旋支撑环区域的结构差异,并展示了ScTopoII中亲水和疏水分子内相互作用的独特模式。此外,系统发育比较支持所研究特定区域的重要性。该研究包括来自不同生物的拓扑异构酶,突出了K环附近螺旋稳定性的差异以及螺旋支撑环区域的作用。这一广泛分析为人类和真菌酶的结构基础提供了见解,揭示了ScTopoII中潜在的药效团“热点”,这可能为开发选择性抗真菌剂带来希望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/11923201/07c30acbfaba/41598_2025_93122_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/11923201/f771a33c8032/41598_2025_93122_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/11923201/2de99b26c163/41598_2025_93122_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/11923201/04367afdcc46/41598_2025_93122_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/11923201/07c30acbfaba/41598_2025_93122_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/11923201/f771a33c8032/41598_2025_93122_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/11923201/2de99b26c163/41598_2025_93122_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/11923201/04367afdcc46/41598_2025_93122_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/11923201/07c30acbfaba/41598_2025_93122_Fig4_HTML.jpg

相似文献

1
Structural insights into fungal and human topoisomerase II with implications for in silico antifungal drug design.对真菌和人类拓扑异构酶II的结构见解及其对计算机辅助抗真菌药物设计的启示。
Sci Rep. 2025 Mar 19;15(1):9467. doi: 10.1038/s41598-025-93122-1.
2
Pharmacoinformatics analysis of merbarone binding site in human topoisomerase IIα.人拓扑异构酶 IIα 中梅拉酮结合位点的药物信息学分析。
J Mol Graph Model. 2019 Jan;86:1-18. doi: 10.1016/j.jmgm.2018.09.013. Epub 2018 Sep 27.
3
Pharmacophore Hybridization To Discover Novel Topoisomerase II Poisons with Promising Antiproliferative Activity.基于药效团杂交发现具有潜在抗增殖活性的新型拓扑异构酶 II 抑制剂。
J Med Chem. 2018 Feb 8;61(3):1375-1379. doi: 10.1021/acs.jmedchem.7b01388. Epub 2017 Nov 9.
4
Bioassays and In Silico Methods in the Identification of Human DNA Topoisomerase IIα Inhibitors.生物测定法和计算机方法在鉴定人类 DNA 拓扑异构酶 IIα 抑制剂中的应用。
Curr Med Chem. 2018;25(28):3286-3318. doi: 10.2174/0929867325666180306165725.
5
Novel DNA topoisomerase IIα inhibitors from combined ligand- and structure-based virtual screening.基于配体和结构的虚拟筛选相结合发现新型DNA拓扑异构酶IIα抑制剂
PLoS One. 2014 Dec 9;9(12):e114904. doi: 10.1371/journal.pone.0114904. eCollection 2014.
6
Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.通过选择性诱变可使人拓扑异构酶IIα对喹诺酮类抗菌药物的敏感性增加。
J Mol Biol. 2000 Jul 14;300(3):481-91. doi: 10.1006/jmbi.2000.3892.
7
DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.DNA拓扑异构酶作为抗癌药物TAS-103的靶点:主要细胞靶点及DNA切割增强作用
Biochemistry. 1999 Nov 23;38(47):15573-9. doi: 10.1021/bi991791o.
8
A new 1-nitro-9-aminoacridine derivative targeting yeast topoisomerase II able to overcome fluconazole-resistance.一种新型的靶向酵母拓扑异构酶 II 的 1-硝基-9-氨基吖啶衍生物,能够克服氟康唑耐药性。
Bioorg Med Chem Lett. 2021 Mar 1;35:127815. doi: 10.1016/j.bmcl.2021.127815. Epub 2021 Jan 21.
9
Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.探究细胞毒性双二氧哌嗪ICRF-193与人拓扑异构酶IIα的封闭酶钳的相互作用。
Mol Pharmacol. 2000 Sep;58(3):560-8. doi: 10.1124/mol.58.3.560.
10
Analysis of functional domain organization in DNA topoisomerase II from humans and Saccharomyces cerevisiae.人类和酿酒酵母DNA拓扑异构酶II功能域组织分析。
Mol Cell Biol. 1996 Jul;16(7):3866-77. doi: 10.1128/MCB.16.7.3866.

本文引用的文献

1
Modeling allosteric mechanisms of eukaryotic type II topoisomerases.建模真核 II 型拓扑异构酶的变构机制。
Biophys J. 2024 Jun 18;123(12):1620-1634. doi: 10.1016/j.bpj.2024.05.004. Epub 2024 May 8.
2
Unveiling the interdomain dynamics of type II DNA topoisomerase through all-atom simulations: Implications for understanding its catalytic cycle.通过全原子模拟揭示II型DNA拓扑异构酶的结构域间动力学:对理解其催化循环的启示
Comput Struct Biotechnol J. 2023 Jul 22;21:3746-3759. doi: 10.1016/j.csbj.2023.07.019. eCollection 2023.
3
Targeting DNA Topoisomerase II in Antifungal Chemotherapy.
抗真菌化疗中靶向 DNA 拓扑异构酶 II
Molecules. 2022 Nov 11;27(22):7768. doi: 10.3390/molecules27227768.
4
Evolution: Divergent trajectories predate the origins of animals and fungi.进化:分歧轨迹早于动物和真菌的起源。
Curr Biol. 2022 Nov 7;32(21):R1242-R1244. doi: 10.1016/j.cub.2022.09.047.
5
Divergent genomic trajectories predate the origin of animals and fungi.不同的基因组轨迹早于动物和真菌的起源。
Nature. 2022 Sep;609(7928):747-753. doi: 10.1038/s41586-022-05110-4. Epub 2022 Aug 24.
6
Catalytic Mechanism of ATP Hydrolysis in the ATPase Domain of Human DNA Topoisomerase IIα.人源拓扑异构酶 IIα 的 ATP 酶结构域中 ATP 水解的催化机制。
J Chem Inf Model. 2022 Aug 22;62(16):3896-3909. doi: 10.1021/acs.jcim.2c00303. Epub 2022 Aug 10.
7
ColabFold: making protein folding accessible to all.ColabFold:让蛋白质折叠变得人人可用。
Nat Methods. 2022 Jun;19(6):679-682. doi: 10.1038/s41592-022-01488-1. Epub 2022 May 30.
8
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
9
Structural basis for allosteric regulation of Human Topoisomerase IIα.别构调节人拓扑异构酶 IIα 的结构基础。
Nat Commun. 2021 May 20;12(1):2962. doi: 10.1038/s41467-021-23136-6.
10
DNA topoisomerases: Advances in understanding of cellular roles and multi-protein complexes via structure-function analysis.DNA 拓扑异构酶:通过结构-功能分析深入了解细胞作用和多蛋白复合物。
Bioessays. 2021 Apr;43(4):e2000286. doi: 10.1002/bies.202000286. Epub 2021 Jan 22.